New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 6, 2014
13:43 EDTOREXOrexigen Therapeutics volatility elevated into PDUFA
Orexigen Therapeutics June call option implied volatility is at 164, July is at 116, October is at 88; compared to its 26-week average of 81 according to Track Data, suggesting large movement into the PDUFA goal date of June 10 for Contrave.
News For OREX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 21, 2015
10:12 EDTOREXOptions with decreasing implied volatility
Subscribe for More Information
May 13, 2015
08:08 EDTOREXOrexigen price target lowered to $8 from $11 at Leerink
Subscribe for More Information
May 12, 2015
19:33 EDTOREXOrexigen provides update on Contrave collaboration with Takeda
Subscribe for More Information
19:32 EDTOREXOrexigen provides statement on termination of Light Study
Subscribe for More Information
17:54 EDTOREXOn The Fly: After Hours Movers
Subscribe for More Information
17:52 EDTOREXTakeda requesting Orexigen to pay cost of second heart trial, Bloomberg says
Subscribe for More Information
15:17 EDTOREXOrexigen weakness a buying opportunity, says Piper Jaffray
Subscribe for More Information
08:38 EDTOREXTakeda and Orexigen accept recommendation of the ESC
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use